Nathaniel Erdmann

2.9k total citations
14 papers, 194 citations indexed

About

Nathaniel Erdmann is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Nathaniel Erdmann has authored 14 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Nathaniel Erdmann's work include SARS-CoV-2 and COVID-19 Research (5 papers), Long-Term Effects of COVID-19 (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Nathaniel Erdmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Long-Term Effects of COVID-19 (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Nathaniel Erdmann collaborates with scholars based in United States, Poland and Egypt. Nathaniel Erdmann's co-authors include Michael S. Piepenbrink, Andreas Loos, Michael J. Patton, Jennifer Woo, Sanghita Sarkar, Paul A. Goepfert, James J. Kobie, Jun‐Gyu Park, Chengjin Ye and Matthew Might and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS Pathogens and Critical Care.

In The Last Decade

Nathaniel Erdmann

13 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathaniel Erdmann United States	8	116	53	33	24	22	14	194
Ambrogio Curtolo Italy	8	61 0.5×	76 1.4×	17 0.5×	24 1.0×	13 0.6×	14	240
И. В. Шлык Russia	6	71 0.6×	38 0.7×	16 0.5×	34 1.4×	17 0.8×	46	158
Eva Tabernero Spain	5	154 1.3×	45 0.8×	14 0.4×	35 1.5×	10 0.5×	11	200
Carlos Dueñas Spain	10	159 1.4×	73 1.4×	19 0.6×	53 2.2×	8 0.4×	29	236
Sandra Rajme‐López Mexico	8	107 0.9×	39 0.7×	18 0.5×	30 1.3×	15 0.7×	26	232
Jan‐Erik Berdal Norway	8	96 0.8×	94 1.8×	33 1.0×	25 1.0×	20 0.9×	16	252
Claudio Acevedo Switzerland	8	87 0.8×	58 1.1×	29 0.9×	31 1.3×	36 1.6×	11	204
Mohammad Reza Salehi Iran	8	102 0.9×	69 1.3×	12 0.4×	33 1.4×	16 0.7×	17	185
Wolfgang Bauer Germany	7	80 0.7×	68 1.3×	25 0.8×	8 0.3×	46 2.1×	13	187
Elda De Vita Italy	8	54 0.5×	20 0.4×	17 0.5×	8 0.3×	40 1.8×	24	184

Countries citing papers authored by Nathaniel Erdmann

Since Specialization

Citations

This map shows the geographic impact of Nathaniel Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Erdmann more than expected).

Fields of papers citing papers by Nathaniel Erdmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Erdmann. The network helps show where Nathaniel Erdmann may publish in the future.

Co-authorship network of co-authors of Nathaniel Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel Erdmann. A scholar is included among the top collaborators of Nathaniel Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel Erdmann. Nathaniel Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Piepenbrink, Michael S., Ahmed Magdy Khalil, Ahmed Mostafa, et al.. (2024). Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants. SHILAP Revista de lepidopterología. 2(1). 55–55. 3 indexed citations

Patton, Michael J., D. Benson, Sarah W. Robison, et al.. (2024). Characteristics and determinants of pulmonary long COVID. JCI Insight. 9(10). 7 indexed citations

Erdmann, Nathaniel & Sonya L. Heath. (2024). Cytokine Storm Syndrome as a Manifestation of Primary HIV Infection. Advances in experimental medicine and biology. 1448. 269–274. 2 indexed citations

Files, Jacob K., et al.. (2024). Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2. JAIDS Journal of Acquired Immune Deficiency Syndromes. 96(1). 92–100.

Patton, Michael J., Carlos J. Orihuela, Kevin S. Harrod, et al.. (2023). COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Critical Care. 27(1). 34–34. 50 indexed citations

Margaroli, Camilla, Nirmal Sharma, Siddharth Patel, et al.. (2023). Interferon-dependent signaling is critical for viral clearance in airway neutrophils. JCI Insight. 8(10). 6 indexed citations

Piepenbrink, Michael S., Jun‐Gyu Park, Ashlesha Deshpande, et al.. (2022). Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody. PLoS Pathogens. 18(7). e1010691–e1010691. 18 indexed citations

Killian, John T., Julie A. Houp, Greer Burkholder, et al.. (2022). COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19. Transplant International. 35. 10626–10626. 5 indexed citations

Piepenbrink, Michael S., Jun‐Gyu Park, Fatai S. Oladunni, et al.. (2021). Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters. Cell Reports Medicine. 2(3). 100218–100218. 50 indexed citations

10.

Raines, Nathan H., Landon Wilson, Jeffrey C. Edberg, et al.. (2021). Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19–Related Acute Kidney Injury. Kidney International Reports. 6(12). 3002–3013. 18 indexed citations

11.

Erdmann, Nathaniel, et al.. (2021). Single-Cell RNA Sequencing of Urinary Cells Reveals Distinct Cellular Diversity in COVID-19–Associated AKI. Kidney360. 3(1). 28–36. 16 indexed citations

12.

Shrestha, Sadeep, Greer Burkholder, Anju Bansal, et al.. (2020). Rates and Correlates of Incident Type 2 Diabetes Mellitus Among Persons Living With HIV-1 Infection. Frontiers in Endocrinology. 11. 8 indexed citations

13.

Erdmann, Nathaniel, Heather A. Prentice, Anju Bansal, et al.. (2018). Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy. Frontiers in Public Health. 6. 70–70. 10 indexed citations

14.

Westfall, Andrew O., et al.. (2018). Neutrophil Proportions Are Comparable to Lactic Acid in Predicting Outcomes in Trauma Patients. Journal of the American College of Surgeons. 227(4). e63–e63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact